Why it Matters

A provision to delay a federal ban on hemp-derived THC products has become one of the most divisive fights in the current Senate spending debate, with the White House directly lobbying Republican senators who want the ban to proceed on schedule — and conflict-of-interest allegations now adding fuel to the standoff.

The Senate's continuing resolution (CR) to keep the government funded through December includes a provision that would push the effective date of a hemp ban from Nov. 12 to Dec. 11. The House-passed version of the CR does not include the delay, setting up a potential standoff that could threaten the entire funding bill.

The Background

The underlying ban stems from language embedded in the fiscal year 2026 Agriculture Appropriations Act, which redefined hemp and set a ban on hemp-derived THC products to take effect this November. The 30-day delay provision in the Senate CR has fractured the GOP, pitting social conservatives focused on child safety against senators and the White House aligned with the hemp industry.

The New York Times reported on Aug. 5 that the delay provision was inserted into the spending bill at the White House's request, and that it could benefit the son-in-law of Susie Wiles, Trump's chief of staff, who has ties to the hemp industry. The White House denied any conflict of interest, saying Wiles "has never lobbied in favor of this or any other position on hemp with Capitol Hill."

The Daily Caller reported on Aug. 6 that the intra-GOP fight is now raising concerns the dispute could sink the entire spending bill and potentially trigger a government shutdown.

What They're Saying

President Trump personally called Sen. Ted Budd (R-N.C.) on Aug. 5 to urge him to back off his opposition to the hemp delay provision, according to Axios and Politico. A White House spokesperson pointed to an April 23 Truth Social post as the definitive statement of Trump's position, in which he wrote: "I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress's intent to restrict the sale of products that pose Health risks."

Budd responded by filing an amendment to strip the delay from the CR entirely, saying: "I'm offering an amendment to the CR to strip out an extension of the hemp loophole to ensure unregulated, dangerous intoxicants are not sold, especially to kids." Sens. Tom Cotton (R-Ark.) and Pete Ricketts (R-Neb.) aligned with Budd. Cotton called the products "gas-station drugs," and a Ricketts spokeswoman said they were "hurting our kids and communities."

On the other side, Sens. Rand Paul (R-Ky.) and Amy Klobuchar (D-Minn.) introduced the bipartisan Hemp Safety Enforcement Act, which would empower states and tribal governments to regulate hemp products rather than impose a blanket federal ban. Their offices warned that "the hemp sector faces extinction" under the current appropriations language. Klobuchar also celebrated the Senate CR's delay provision, saying it would allow states to "put more sensible safety rules in place."

Sen. Patty Murray (D-Wash.), the top Democrat on the Appropriations Committee, framed the broader budget fight in starker terms: "Enabling this rule would only give Trump the green light to take even more federal funding hostage."

Access the Legis1 platform for comprehensive political news, data, and insights.

Spot something wrong? Report an issue with this article